Serum Immunoreactive Leptin Concentrations in Patients with Anorexia Nervosa before and after Partial Weight Recovery

Felipe F. Casanueva , Carlos Dieguez , Vera Popovic , Roberto Peino , Robert V. Considine , Jose F. Caro
{"title":"Serum Immunoreactive Leptin Concentrations in Patients with Anorexia Nervosa before and after Partial Weight Recovery","authors":"Felipe F. Casanueva ,&nbsp;Carlos Dieguez ,&nbsp;Vera Popovic ,&nbsp;Roberto Peino ,&nbsp;Robert V. Considine ,&nbsp;Jose F. Caro","doi":"10.1006/bmme.1996.2564","DOIUrl":null,"url":null,"abstract":"<div><p>Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. In order to understand the role of leptin in severe malnutrition, in the present work 10 patients recently diagnosed with anorexia nervosa were studied both before and 2 months later, after partial weight recovery, and were compared with 18 normal-weight women as controls. Leptin was measured by a newly developed radioimmunoassay and both IGF-I and IGFBP-3 were measured by commercial radioimmunoassays. The mean (±SE) serum leptin concentrations (in μg/liter) were 18.1 ± 2.0 in control women with BMI of 21.1 ± 0.3, significantly higher (<em>P</em>&lt; 0.01) than that in the anorexia nervosa patients at diagnosis (2.2 ± 0.1, BMI 15.3 ± 0.6). These differences were also observed in IGF-I values (μg/liter) that were 228.0 ± 14.6 in controls and 157.4 ± 28.7 in anorexia nervosa patients (<em>P</em>&lt; 0.02). No differences were observed in IGF-BP3. After treatment, patients with anorexia nervosa experienced an increase in BMI (17.1 ± 0.5,<em>P</em>&lt; 0.0001 vs before) although they were still underweight. The partial recovery in weight led to a complete normalization of IGF-I levels (214.0 ± 21.0 μg/liter) and to an enhancement in leptin levels (3.3 ± 0.5 μg/liter;<em>P</em>&lt; 0.03 vs before treatment), though still lower than those in normal-weight women (P &lt; 0.05). Individually analyzed, a large dispersion was observed in control subjects, with leptin levels ranging from 5.5 to 38.7 μg/liter, while in all anorexia nervosa patients leptin levels were under 3 μg/liter. A treatment-induced increase in body weight led to an increase in leptin levels in 7 out of the 10 anorexia nervosa patients studied and the 3 patients with no increase in leptin were all initially under the 14.5 BMI. In conclusion, leptin levels are severely reduced in anorexia nervosa patients with severe malnutrition, and a significant rise occurred after partial weight recovery. There seems to be a level of BMI below which leptin levels do not drop further but also do not increase despite weight gain. While IGF-I reflects the energy intake of the previous few weeks, the serum leptin concentration reflects the true status of the adipose stores, a fact that has useful clinical implications.</p></div>","PeriodicalId":8837,"journal":{"name":"Biochemical and molecular medicine","volume":"60 2","pages":"Pages 116-120"},"PeriodicalIF":0.0000,"publicationDate":"1997-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/bmme.1996.2564","citationCount":"76","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical and molecular medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1077315096925648","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 76

Abstract

Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. In order to understand the role of leptin in severe malnutrition, in the present work 10 patients recently diagnosed with anorexia nervosa were studied both before and 2 months later, after partial weight recovery, and were compared with 18 normal-weight women as controls. Leptin was measured by a newly developed radioimmunoassay and both IGF-I and IGFBP-3 were measured by commercial radioimmunoassays. The mean (±SE) serum leptin concentrations (in μg/liter) were 18.1 ± 2.0 in control women with BMI of 21.1 ± 0.3, significantly higher (P< 0.01) than that in the anorexia nervosa patients at diagnosis (2.2 ± 0.1, BMI 15.3 ± 0.6). These differences were also observed in IGF-I values (μg/liter) that were 228.0 ± 14.6 in controls and 157.4 ± 28.7 in anorexia nervosa patients (P< 0.02). No differences were observed in IGF-BP3. After treatment, patients with anorexia nervosa experienced an increase in BMI (17.1 ± 0.5,P< 0.0001 vs before) although they were still underweight. The partial recovery in weight led to a complete normalization of IGF-I levels (214.0 ± 21.0 μg/liter) and to an enhancement in leptin levels (3.3 ± 0.5 μg/liter;P< 0.03 vs before treatment), though still lower than those in normal-weight women (P < 0.05). Individually analyzed, a large dispersion was observed in control subjects, with leptin levels ranging from 5.5 to 38.7 μg/liter, while in all anorexia nervosa patients leptin levels were under 3 μg/liter. A treatment-induced increase in body weight led to an increase in leptin levels in 7 out of the 10 anorexia nervosa patients studied and the 3 patients with no increase in leptin were all initially under the 14.5 BMI. In conclusion, leptin levels are severely reduced in anorexia nervosa patients with severe malnutrition, and a significant rise occurred after partial weight recovery. There seems to be a level of BMI below which leptin levels do not drop further but also do not increase despite weight gain. While IGF-I reflects the energy intake of the previous few weeks, the serum leptin concentration reflects the true status of the adipose stores, a fact that has useful clinical implications.

神经性厌食症患者体重部分恢复前后血清免疫反应性瘦素浓度的变化
瘦素是ob基因的产物,是最近发现的一种由脂肪细胞分泌的激素。血清瘦素浓度的增加与体脂百分比相关,但除此之外,人们对瘦素在人体中的生理作用知之甚少。为了了解瘦素在严重营养不良中的作用,本研究对10例新近诊断为神经性厌食症的患者在体重部分恢复前和2个月后进行了研究,并与18名体重正常的女性作为对照。瘦素用新开发的放射免疫法测定,IGF-I和IGFBP-3用商业放射免疫法测定。BMI为21.1±0.3的对照组血清瘦素浓度(μg/l)平均值(±SE)为18.1±2.0,显著高于对照组(P<诊断时神经性厌食症患者BMI指数为(2.2±0.1,15.3±0.6)。IGF-I值(μg/l)也存在差异,对照组为228.0±14.6,神经性厌食症患者为157.4±28.7 (P<0.02)。IGF-BP3未见差异。治疗后神经性厌食症患者BMI升高(17.1±0.5,P<0.0001 vs以前),尽管他们仍然体重不足。体重部分恢复导致IGF-I水平完全正常化(214.0±21.0 μg/l),瘦素水平增强(3.3±0.5 μg/l);0.03 vs治疗前),但仍低于正常体重妇女(P <0.05)。个体分析显示,对照组瘦素水平在5.5 ~ 38.7 μg/l之间,而所有神经性厌食症患者瘦素水平均在3 μg/l以下。治疗引起的体重增加导致10名神经性厌食症患者中有7名瘦素水平升高,而3名瘦素水平未升高的患者最初均低于14.5 BMI。综上所述,重度营养不良的神经性厌食症患者瘦素水平严重降低,部分体重恢复后明显升高。体重指数低于某一水平时,瘦素水平不会进一步下降,即使体重增加也不会增加。虽然igf - 1反映了前几周的能量摄入,但血清瘦素浓度反映了脂肪储存的真实状态,这一事实具有有用的临床意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信